92 related articles for article (PubMed ID: 17889328)
1. Assessing neuroprotective P-glycoprotein activity at the blood-brain barrier in killifish (Fundulus heteroclitus) using behavioural profiles.
Bard SM; Gadbois S
Mar Environ Res; 2007 Dec; 64(5):679-82. PubMed ID: 17889328
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of P-glycoprotein in the blood-brain barrier alters avermectin neurotoxicity and swimming performance in rainbow trout.
Kennedy CJ; Tierney KB; Mittelstadt M
Aquat Toxicol; 2014 Jan; 146():176-85. PubMed ID: 24316435
[TBL] [Abstract][Full Text] [Related]
3. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans.
Macdonald N; Gledhill A
Arch Toxicol; 2007 Aug; 81(8):553-63. PubMed ID: 17354009
[TBL] [Abstract][Full Text] [Related]
4. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
Caminada D; Zaja R; Smital T; Fent K
Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
[TBL] [Abstract][Full Text] [Related]
5. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
[TBL] [Abstract][Full Text] [Related]
6. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.
Griffin J; Fletcher N; Clemence R; Blanchflower S; Brayden DJ
J Vet Pharmacol Ther; 2005 Jun; 28(3):257-65. PubMed ID: 15953199
[TBL] [Abstract][Full Text] [Related]
7. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
Hsiao P; Bui T; Ho RJ; Unadkat JD
Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
[TBL] [Abstract][Full Text] [Related]
8. Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model.
Vautier S; Milane A; Fernandez C; Buyse M; Chacun H; Farinotti R
Neurosci Lett; 2008 Sep; 442(1):19-23. PubMed ID: 18598736
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
Yang ZH; Liu XD
Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
[TBL] [Abstract][Full Text] [Related]
10. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin.
Hugnet C; Lespine A; Alvinerie M
J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794
[TBL] [Abstract][Full Text] [Related]
11. Assessment of antiepileptic drugs as substrates for canine P-glycoprotein.
West CL; Mealey KL
Am J Vet Res; 2007 Oct; 68(10):1106-10. PubMed ID: 17916018
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.
Bartley DJ; McAllister H; Bartley Y; Dupuy J; Ménez C; Alvinerie M; Jackson F; Lespine A
Parasitology; 2009 Aug; 136(9):1081-8. PubMed ID: 19549355
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine p-glycoprotein knockout model.
Mealey KL; Greene S; Bagley R; Gay J; Tucker R; Gavin P; Schmidt K; Nelson F
Drug Metab Dispos; 2008 Jun; 36(6):1073-9. PubMed ID: 18332085
[TBL] [Abstract][Full Text] [Related]
14. Fundulus heteroclitus: ovarian reproductive physiology and the impact of environmental contaminants.
Lister AL; Van Der Kraak GJ; Rutherford R; MacLatchy D
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Nov; 154(4):278-87. PubMed ID: 21771666
[TBL] [Abstract][Full Text] [Related]
15. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway.
Liu H; Yang H; Wang D; Liu Y; Liu X; Li Y; Xie L; Wang G
Eur J Pharmacol; 2009 Jan; 602(2-3):277-82. PubMed ID: 19049803
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.
Spudich A; Kilic E; Xing H; Kilic U; Rentsch KM; Wunderli-Allenspach H; Bassetti CL; Hermann DM
Nat Neurosci; 2006 Apr; 9(4):487-8. PubMed ID: 16565717
[TBL] [Abstract][Full Text] [Related]
17. A putative nicotine pump at the metabolic blood-brain barrier of the tobacco hornworm.
Murray CL; Quaglia M; Arnason JT; Morris CE
J Neurobiol; 1994 Jan; 25(1):23-34. PubMed ID: 7906712
[TBL] [Abstract][Full Text] [Related]
18. Diet influences salinity preference of an estuarine fish, the killifish Fundulus heteroclitus.
Bucking C; Wood CM; Grosell M
J Exp Biol; 2012 Jun; 215(Pt 11):1965-74. PubMed ID: 22573776
[TBL] [Abstract][Full Text] [Related]
19. The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier.
Khan EU; Reichel A; Begley DJ; Roffey SJ; Jezequel SG; Abbott NJ
Int J Clin Pharmacol Ther; 1998 Feb; 36(2):84-6. PubMed ID: 9520152
[No Abstract] [Full Text] [Related]
20. Expression of P-glycoprotein in killifish (Fundulus heteroclitus) exposed to environmental xenobiotics.
Bard SM; Bello SM; Hahn ME; Stegeman JJ
Aquat Toxicol; 2002 Sep; 59(3-4):237-51. PubMed ID: 12127740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
